Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 60,465Xls
2D Structure
Also known as: 1228088-30-9, Rg7314, Ro5285119, Balovaptan [inn], Balovaptan [usan], Rax5d5agv6
Molecular Formula
C22H24ClN5O
Molecular Weight
409.9  g/mol
InChI Key
GMPZPHGHNDMRKL-UHFFFAOYSA-N
FDA UNII
RAX5D5AGV6

Balovaptan is under investigation in clinical trial NCT01793441 (A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)).
1 2D Structure

2D Structure

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
8-chloro-5-methyl-1-(4-pyridin-2-yloxycyclohexyl)-4,6-dihydro-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine
2.1.2 InChI
InChI=1S/C22H24ClN5O/c1-27-13-16-12-17(23)7-10-19(16)28-20(14-27)25-26-22(28)15-5-8-18(9-6-15)29-21-4-2-3-11-24-21/h2-4,7,10-12,15,18H,5-6,8-9,13-14H2,1H3
2.1.3 InChI Key
GMPZPHGHNDMRKL-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CN1CC2=C(C=CC(=C2)Cl)N3C(=NN=C3C4CCC(CC4)OC5=CC=CC=N5)C1
2.2 Other Identifiers
2.2.1 UNII
RAX5D5AGV6
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 4h-(1,2,4)triazolo(4,3-a)(1,4)benzodiazepine, 8-chloro-5,6-dihydro-5-methyl-1-(trans-4-(2-pyridinyloxy)cyclohexyl)-

2. 8-chloro-5-methyl-1-(trans-4-(2-pyridinyloxy)cyclohexyl)-5,6-dihydro-4h-(1,2,4)triazolo(4,3-a)(1,4)benzodiazepine

2.3.2 Depositor-Supplied Synonyms

1. 1228088-30-9

2. Rg7314

3. Ro5285119

4. Balovaptan [inn]

5. Balovaptan [usan]

6. Rax5d5agv6

7. Rg-7314

8. Ro-5285119

9. 8-chloro-5-methyl-1-(4-pyridin-2-yloxycyclohexyl)-4,6-dihydro-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine

10. 4h-(1,2,4)triazolo(4,3-a)(1,4)benzodiazepine, 8-chloro-5,6-dihydro-5-methyl-1-(trans-4-(2-pyridinyloxy)cyclohexyl)-

11. 8-chloro-5-methyl-1-{trans-4-[(pyridin-2-yl)oxy]cyclohexyl}-5,6-dihydro-4h-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine

12. Balovaptan (usan/inn)

13. Balovaptan [usan:inn]

14. Unii-rax5d5agv6

15. Balovaptan [who-dd]

16. Schembl2471320

17. Schembl3329710

18. Schembl3332136

19. Chembl4297183

20. Gtpl10615

21. Dtxsid101107286

22. Bdbm50546439

23. Akos037648594

24. Compound 1 [pmid: 31951127]

25. Db14823

26. Sb19643

27. Bs-14780

28. Hy-109024

29. Cs-0030526

30. D11476

31. D80511

32. 12-chloro-8-methyl-3-[(1r,4r)-4-(pyridin-2-yloxy)cyclohexyl]-2,4,5,8-tetraazatricyclo[8.4.0.0(2),]tetradeca-1(10),3,5,11,13-pentaene

33. 8-chloro-5,6-dihydro-5-methyl-1-[trans-4-(2-pyridinyloxy)cyclohexyl]-4h-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine

34. 8-chloro-5-methyl-1-(trans-4-(2-pyridinyloxy)cyclohexyl)-5,6-dihydro-4h-(1,2,4)triazolo(4,3-a)(1,4)benzodiazepine

35. 8-chloro-5-methyl-1-(trans-4-(pyridin-2-yloxy)cyclohexyl)-5,6-dihydro-4h-(1,2,4)triazolo(4,3-a)(1,4)benzodiazepine

2.4 Create Date
2010-07-06
3 Chemical and Physical Properties
Molecular Weight 409.9 g/mol
Molecular Formula C22H24ClN5O
XLogP33.4
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count5
Rotatable Bond Count3
Exact Mass409.1669381 g/mol
Monoisotopic Mass409.1669381 g/mol
Topological Polar Surface Area56.1 Ų
Heavy Atom Count29
Formal Charge0
Complexity545
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Indication

Treatment of autism spectrum disorder


5 Pharmacology and Biochemistry
5.1 MeSH Pharmacological Classification

Antidiuretic Hormone Receptor Antagonists

Endogenous compounds and drugs that inhibit or block the activity of ANTIDUIRETIC HORMONE RECEPTORS. (See all compounds classified as Antidiuretic Hormone Receptor Antagonists.)